Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04537481
Other study ID # L0805
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 3, 2020
Est. completion date December 31, 2020

Study information

Verified date August 2020
Source Tang-Du Hospital
Contact Wang Ming, Master
Phone 8613259809290
Email wangmingbio@snnu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although in vitro fertilization (IVF) involve the use of semen samples, there is little scientific methodology applied when selecting sperm. To select the most appropriate spermatozoa, first the operator need to define the optimal molecular markers. Sperm lipids may contribute to sperm function, thus the investigator's aim was to compare the lipidic profiles differences of sperm samples used in IVF cycles that ultimately led to normal fertilization or low fertilization.


Description:

There is increasing evidence that male fertility/infertility and sperm physiology are determined by multiple factors, necessitating the use of numerous molecular biomarkers to precisely assess male reproductive potential. The study has reported that the lipids are special interest as fertility markers and therapeutic targets not only due to their functions in sperm, but also because they are sensitive to external and environmental signals.

Sperm samples from infertile patients after IVF ( normal fertilization group, n=25; low fertilization group, n=25) were collected. Following standard density gradient separation operating procedure, the sample were incubated in 37°C, 5%CO2, for 3 hours. The sample included 10x10^6 spermatozoa after sample preparation and aliquots in 100 μL PBS were analyzed for lipid composition using ultra-high performance liquid chromatography coupled to mass spectrometry. Lipid compositions and levels were compared between the two groups. The results will describe the composition and contents of lipids linked to capacitation of sperm, opening a new possibilities for the development of male fertility diagnostic tools and culture media formulations to improve sperm quality and enhance fertilization result.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2020
Est. primary completion date October 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 22 Years to 35 Years
Eligibility Inclusion Criteria:

- Tubal factor infertility,

- The women's BMI (Body mass index) ranged from 18.5 to 24,

- The women's AMH (Anti-Müllerian hormone) ranged from 2 to 6.8 ng/ml,

- The oocyte mature rate was greater than 75%,

- 8 = Number of retrieved oocytes = 16.

- Analysis of the spouse's semen conventional parameters showed normal.

Exclusion Criteria:

- The age is over 35 years old.

- The women with polycystic ovary syndrome (PCOS).

- The endocrine function of the women was disordered.

- The women has metabolic disease.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Lipid extraction
The sperm samples were used for lipid extraction. Lipids were analyzed using the UPLC-MS system.

Locations

Country Name City State
China Tangdu Hospital Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Tang-Du Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Normal fertilization rate 2PN (two pronuclei and two polar bodies) rate 6 months
See also
  Status Clinical Trial Phase
Completed NCT01558141 - Follicular Flushing N/A
Not yet recruiting NCT04519918 - Clinical Application of Artificial Oocyte Activation Technique (AOA) in ART N/A
Recruiting NCT03810001 - Mechanical Stimulation Improve the Fertilization in ICSI Cycle N/A
Not yet recruiting NCT04523103 - Artificial Assisted Activation Following in Fertilization Failure N/A
Completed NCT00340587 - Human Sperm Binding to Transgenic Mouse Eggs
Completed NCT00598208 - A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED) Phase 2
Not yet recruiting NCT06433518 - BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)
Completed NCT02913781 - Polar Body Removal Before ICSI for Oocyte Activation in Previous Fertilization Failure Cases N/A
Completed NCT01223118 - Evaluation of the Impact of Vitrification on Oocytes N/A